Tumor angiogenesis in gynecological oncology

Journal of B.U.ON.

Volumn 7, Issue 1, 2002, Pages 19-23

  Mandić, Aljoša ^a   Vujkov, T ^a   Novakovic P ^a   Komazec, S ^a  

^a Institute of Oncology Sremska Kamenica   (Yugoslavia)

Author keywords

Angiogenesis; Gynecological cancers; Microvessel density; Neoangiogenesis; Vascular endothelial growth factor

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; PEPTIDE; VASCULOTROPIN;

ANGIOGENESIS; BLOOD VESSEL PARAMETERS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RESEARCH; CELL MIGRATION; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE MARKER; ENDOMETRIUM CARCINOMA; GYNECOLOGIC CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; OVARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA; TREATMENT PLANNING; TUMOR GROWTH; TUMOR VASCULARIZATION; UTERINE CERVIX CARCINOMA; UTERINE TUBE CARCINOMA; VASCULAR ENDOTHELIUM; VULVA CARCINOMA;

EID: 0036249314     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Angiogenesis
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Tumor angiogenesis. Therapeutic implication
4. Angiogenesis in cancer, vascular, rheumatoid and other diseases
5. Angiogenic factors
6. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors
7. Vascular endothelial growth factor: Acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803
8. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
9. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells
10. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
11. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
12. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells
13. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: Correlation with neovascularization
14. Examining the technique of angiogenesis assessment in invasive breast cancer
15. What is the evidence that tumors are angiogenesis-dependent?
16. The diagnostic and prognostic value of tumor angiogenesis
17. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
18. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis
19. La morphogenèse de l'arbre vasculaire. De la compréhension des mécanismes moléculaires aux perspectives thérapeutiques
20. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
21. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
22. Immunohistochemical analysis of integrin alphaVbeta 3 expression on tumor-associated vessels of human carcinomas
23. Vascular integrin alphaVbeta 3: A new prognostic indicator in breast cancer
24. Angiogenesis in gynecology and obstetrics
25. Vascular endothelial growth factor expression in early-stage ovarian carcinoma
26. Expression of vascular endothelial growth factor and its receptors fit and KDR in ovarian carcinoma
27. Secretion of vascular endothelial growth factor in ovarian cancer
28. Vascular endothelial growth factor serum concentrations in ovarian cancer
29. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer
30. The prognostic significance of angiogenesis in epithelial ovarian carcinoma
31. Diagnostic value of serum VEGF in women with ovarian tumors
32. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
33. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
34. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
35. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer
36. Tumor angiogenesis in advanced-stage ovarian carcinoma
37. Prognostic significance of tumor angiogenesis in primary fallopian tube cancer
38. Angiogenesis in normal, hyperplastic and neoplastic endometrium
39. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma
40. Prognostic significance of tumor angiogenesis in endometrial cancer
41. Angiogenesis in endometrial cancer
42. Angiogenesis factor in endometrial carcinoma: A new prognostic indicator?
43. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer
44. National program of early detection and treatment of uterine cervical cancer
45. Correlation of vascular endothelial growth factor expression and microvessel density in cervical intraepithelial neoplasia
46. Tumor angiogenesis: An independent prognostic parameter in cervical cancer
47. Tumor angiogenesis in stage IB cervical cancer: Correlation of microvessel density with survival
48. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia
49. Angiogenesis in cervical neoplasia: Microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations
50. Vascular endothelial growth factor is implicated in early invasion in cervical cancer
51. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix
52. Angiogenesis in vulvar intraepithelial neoplasia
53. Role of angiogenesis in benign, premalignant and malignant vulvar lesions
54. Serum concentrations of vascular endothelial growth factor in vulvar cancer
55. Influence of microvessel density and vascular permeability factor/Vascular endothelial growth factor expression on prognosis in vulvar cancer